307 results on '"Fogar, P"'
Search Results
102. ME-PCR for the identification of mutated K-ras in serum and bile of pancreatic cancer patients: an unsatisfactory technique for clinical applications
103. Does Acetylsalicylic Acid Interfere with Stimulated Pancreatic Secretion An Experimental Study in the Rat
104. βCell Function in Pancreatic Adenocarcinoma
105. Comparison of Two Newly Identified Tumor Markers (CAR-3 AND DU-PAN-2) with CA 19-9 in Patients with Pancreatic Cancer
106. Portal but not peripheral serum levels of interleukin 6 could interfere with glucose metabolism in patients with pancreatic cancer
107. Urinary elastase 1 in chronic pancreatic disease
108. Does serum HPP in chronic pancreatic diseases indicate exocrine pancreatic dysfunction and damage ?
109. ERP and pancreatic ultrasonography: role in the diagnosis of chronic pancreatitis and pancreatic cancer
110. Can endoscopic retrograde pancreatography predict the clinical picture and the functional status in chronic pancreatitis?
111. [Role of serum markers and or various clinical parameters in the diagnosis of pancreatic carcinoma]
112. Diabetes mellitus in pancreatic cancer follow-up
113. Cisapride and sucralfate in dyspepsia associated to duodeno-gastric reflux gastritis,CISAPRIDE E SUCRALFATO NELLA DISPEPSIA ASSOCIATA A GASTRITE DA REFLUSSO DUODENO GASTRICO
114. Identification of potential serum biomarkers of pancreatic cancer,Identificazione di potenziali biomarcatori sierici di adenocarcinoma pancreatico
115. VKORC1, CYP2C9 AND CYP4F2 GENETIC BASED ALGORITHM FOR WARFARIN DOSING. PRELIMINARY RESULTS OF A PROSPECTIVE ITALIAN STUDY
116. Different role of liver dysfunction and damage in increasing serum CA 19-9, TPA, and CEA in patients with pancreatic cancer
117. Urinary Elastase 1 in Chronic Pancreatic Disease
118. Prophylaxis with Intrathecal Chemotherapy and High Dose Methotrexate in Patients with Diffuse Large B Cell Lymphoma at High Risk for Central Nervous System Relapse: A Single Centre Experience
119. The Pancreatic Cancer Derived N-Terminal Peptide of S100A8 Stimulates Insulin Exocytosis and HepG2 Cell Growth.
120. Pancreatic Cancer Pulls Down Lymphocyte Migration.
121. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms
122. 1110–1082 and TNFa-863 gene polymorphisms may favor the onset of chronic pancreatic diseases and of the associated diabetes, but not pancreatic cancer outcome
123. MALDI-TOF/MS Biomarkers Discovery for Pancreatic Cancer Diagnosis: Emerging Role of Apolipoprotein A1 and Complement C3.
124. S100A8 and S100A9 Target Akt, mTOR and NF-kB Signalling in Pancreatic Cancer Cells.
125. The Inflammatory Molecules S100A8 and TGF-b1 Activate the Epithelial-Mesenchymal Transition Process in Pancreatic Cancer Cells.
126. Pancreatic Cancer (PaCa)-Derived Soluble Mediators Induce Dendritic Cells (DC) to Acquire an Immunosuppressive Phenotype by Downregulating CTLA4.
127. The Inflammatory Calcium Binding Protein S100A8 and Its N-Terminal Proteolytic Fragment Interact with Transforming Growth Factor-Beta1 (TGF-β1) and Alter Akt, mTOR and NF-kappa B Cancer Cell Signalling.
128. M1757 Pancreatic Cancer Alters CD4+ T Lymphocyte Function: A Piece of the Immunevasion Puzzle.
129. M1587 EPIYA-C Motifs Are Main Determinants of Intestinal Metaplasia and Gastric Mucosa Atrophy.
130. M1558 Pancreatic Cancer Biomarkers Discovery By SELDI-TOF-MS.
131. Heat Shock Responsive Elements (HSEs) Magnify Heat Shock Response of HSP70B' Inducible Promoter. A Promise For Pancreatic Cancer Gene Therapy.
132. Gastropanel: A useful screening test in paediatric populations.
133. The S100A8/A9 complex reduces CTLA4 expression by immature myeloid cells
134. A 2026 D peptide as the putative pancreatic cancer-associated diabetogenic factor
135. Gene therapy with HSV-TK of pancreatic cancer cell lines: Different responses to GCV treatment
136. K-ras point mutations detection in pancreatic cancer serum and bile-derived DNA
137. Pancreatic cancer-derived S-100A8 N-terminal peptide: A diabetes cause?
138. Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study
139. Circulating haematopoietic stem cells and long-term outcomes of COVID-19.
140. Flow Cytometry Analysis in Breast Implant-Associated Anaplastic Large Cell Lymphoma: Three Case Reports.
141. T Cell Senescence by Extensive Phenotyping: An Emerging Feature of COVID-19 Severity.
142. Hyperglycemia, Reduced Hematopoietic Stem Cells, and Outcome of COVID-19.
143. Neonatal lymphocyte subpopulations analysis and maternal preterm premature rupture of membranes: a pilot study.
144. Mucopolysaccharidosis type VII diagnosed from a peripheral blood smear.
145. Monocyte distribution width (MDW) parameter as a sepsis indicator in intensive care units.
146. Traumatic Brain Injury Caused by Work Accidents: How can Occupational and Vocational Recovery be Achieved?
147. Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms.
148. Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation.
149. PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4 -dependent manner through a new calcium related axis.
150. Care pathways models and clinical outcomes in Disorders of consciousness.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.